ImmunoCellular Therapeutics Volatility
| IMUCDelisted Stock | USD 0.47 0.00 0.00% |
We have found eighteen technical indicators for ImmunoCellular Therapeutics, which you can use to evaluate the volatility of the firm. Please check out ImmunoCellular Therapeutics' Market Risk Adjusted Performance of (0.21), standard deviation of 11.82, and Risk Adjusted Performance of (0.04) to validate if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to ImmunoCellular Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
ImmunoCellular Therapeutics Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of ImmunoCellular daily returns, and it is calculated using variance and standard deviation. We also use ImmunoCellular's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of ImmunoCellular Therapeutics volatility.
ImmunoCellular |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as ImmunoCellular Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of ImmunoCellular Therapeutics at lower prices to lower their average cost per share. Similarly, when the prices of ImmunoCellular Therapeutics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against ImmunoCellular Pink Sheet
ImmunoCellular Therapeutics Market Sensitivity And Downside Risk
ImmunoCellular Therapeutics' beta coefficient measures the volatility of ImmunoCellular pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents ImmunoCellular pink sheet's returns against your selected market. In other words, ImmunoCellular Therapeutics's beta of 3.36 provides an investor with an approximation of how much risk ImmunoCellular Therapeutics pink sheet can potentially add to one of your existing portfolios. ImmunoCellular Therapeutics is displaying above-average volatility over the selected time horizon. ImmunoCellular Therapeutics is a potential penny stock. Although ImmunoCellular Therapeutics may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in ImmunoCellular Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on ImmunoCellular instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze ImmunoCellular Therapeutics Demand TrendCheck current 90 days ImmunoCellular Therapeutics correlation with market (Dow Jones Industrial)ImmunoCellular Beta |
ImmunoCellular standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by ImmunoCellular Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of ImmunoCellular Therapeutics' daily returns or price. Since the actual investment returns on holding a position in immunocellular pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in ImmunoCellular Therapeutics.
ImmunoCellular Therapeutics Pink Sheet Volatility Analysis
Volatility refers to the frequency at which ImmunoCellular Therapeutics pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with ImmunoCellular Therapeutics' price changes. Investors will then calculate the volatility of ImmunoCellular Therapeutics' pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of ImmunoCellular Therapeutics' volatility:
Historical Volatility
This type of pink sheet volatility measures ImmunoCellular Therapeutics' fluctuations based on previous trends. It's commonly used to predict ImmunoCellular Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for ImmunoCellular Therapeutics' current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on ImmunoCellular Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
ImmunoCellular Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 3.3612 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ImmunoCellular Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ImmunoCellular Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ImmunoCellular Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ImmunoCellular pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
ImmunoCellular Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives an ImmunoCellular Therapeutics Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.ImmunoCellular Therapeutics Pink Sheet Return Volatility
ImmunoCellular Therapeutics historical daily return volatility represents how much of ImmunoCellular Therapeutics pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7299% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About ImmunoCellular Therapeutics Volatility
Volatility is a rate at which the price of ImmunoCellular Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of ImmunoCellular Therapeutics may increase or decrease. In other words, similar to ImmunoCellular's beta indicator, it measures the risk of ImmunoCellular Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of ImmunoCellular Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Immunocellular Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
ImmunoCellular Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on ImmunoCellular Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much ImmunoCellular Therapeutics' price varies over time.
3 ways to utilize ImmunoCellular Therapeutics' volatility to invest better
Higher ImmunoCellular Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of ImmunoCellular Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. ImmunoCellular Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of ImmunoCellular Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in ImmunoCellular Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of ImmunoCellular Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
ImmunoCellular Therapeutics Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.73 and is 9.223372036854776E16 times more volatile than ImmunoCellular Therapeutics. 0 percent of all equities and portfolios are less risky than ImmunoCellular Therapeutics. You can use ImmunoCellular Therapeutics to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of ImmunoCellular Therapeutics to be traded at $0.4653 in 90 days.Modest diversification
The correlation between ImmunoCellular Therapeutics and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
ImmunoCellular Therapeutics Additional Risk Indicators
The analysis of ImmunoCellular Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in ImmunoCellular Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of ImmunoCellular Therapeutics pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 6.92 | |||
| Coefficient Of Variation | (1,589) | |||
| Standard Deviation | 11.82 | |||
| Variance | 139.69 | |||
| Information Ratio | (0.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
ImmunoCellular Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against ImmunoCellular Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. ImmunoCellular Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, ImmunoCellular Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to ImmunoCellular Therapeutics.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in ImmunoCellular Pink Sheet
If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |